Omnicell Inc (OMCL) Files 10-K for the Fiscal Year Ended on December 31, 2017

In this article:

- By insider

Omnicell Inc (OMCL) files its latest 10-K with SEC for the fiscal year ended on December 31, 2017. Omnicell Inc provides automation and business analytics software solutions for patient-centric medication and supplies management across the entire healthcare continuum, from the acute care hospital setting to post-acute skilled nursing. Omnicell Inc has a market cap of $1.7 billion; its shares were traded at around $44.80 with a P/E ratio of 87.87 and P/S ratio of 2.44. Omnicell Inc had annual average EBITDA growth of 13.70% over the past ten years.


For the last quarter Omnicell Inc reported a revenue of $197.9 million, compared with the revenue of $172.0 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $716.2 million, an increase of 3.4% from last year. For the last five years Omnicell Inc had an average revenue growth rate of 18.7% a year.

The reported diluted earnings per share was 53 cents for the year, an increase of 2550% from previous year. Over the last five years Omnicell Inc had an average EPS decline of 24.7% a year. The Omnicell Inc had an operating margin of 0.8%, compared with the operating margin of 0.94% a year before. The 10-year historical median operating margin of Omnicell Inc is 6.75%. The profitability rank of the company is 7 (out of 10).

At the end of the fiscal year, Omnicell Inc has the cash and cash equivalents of $32.4 million, compared with $54.5 million in the previous year. The long term debt was $194.9 million, compared with $245.7 million in the previous year. The interest coverage to the debt is 3.5. Omnicell Inc has a financial strength rank of 6 (out of 10).

At the current stock price of $44.80, Omnicell Inc is traded at 11.5% premium to its historical median P/S valuation band of $40.19. The P/S ratio of the stock is 2.44, while the historical median P/S ratio is 2.16. The stock gained 18.22% during the past 12 months.

For the complete 20-year historical financial data of OMCL, click here.

This article first appeared on GuruFocus.


Advertisement